HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Matthias L Riess Selected Research

sevoflurane (Ultane)

2/2015Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrest.
12/2014Anaesthetic Postconditioning at the Initiation of CPR Improves Myocardial and Mitochondrial Function in a Pig Model of Prolonged Untreated Ventricular Fibrillation.
4/2008Differential increase of mitochondrial matrix volume by sevoflurane in isolated cardiac mitochondria.
12/2005Increasing heart size and age attenuate anesthetic preconditioning in guinea pig isolated hearts.
9/2005Improved mitochondrial bioenergetics by anesthetic preconditioning during and after 2 hours of 27 degrees C ischemia in isolated hearts.
1/2005Anesthetic preconditioning: the role of free radicals in sevoflurane-induced attenuation of mitochondrial electron transport in Guinea pig isolated hearts.
3/2004Dual exposure to sevoflurane improves anesthetic preconditioning in intact hearts.
8/2003Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts.
4/2003Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts.
2/2003Preconditioning with sevoflurane reduces changes in nicotinamide adenine dinucleotide during ischemia-reperfusion in isolated hearts: reversal by 5-hydroxydecanoic acid.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Matthias L Riess Research Topics

Disease

24Ischemia
10/2015 - 06/2002
8Reperfusion Injury
10/2015 - 02/2003
6Hypothermia
02/2015 - 06/2002
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2014 - 03/2004
3Infarction
01/2014 - 02/2003
2Ventricular Fibrillation
02/2015 - 12/2014
2Heart Arrest (Cardiac Arrest)
02/2015 - 12/2014
2Hypotension (Low Blood Pressure)
01/2013 - 11/2011
1Hyperglycemia
01/2014
1Anoxia (Hypoxia)
01/2014
1Hypertension (High Blood Pressure)
01/2013
1Hemorrhage
11/2011
1Diabetes Mellitus
05/2004

Drug/Important Bio-Agent (IBA)

14sevoflurane (Ultane)FDA LinkGeneric
02/2015 - 07/2002
8NAD (NADH)IBA
02/2012 - 07/2002
55-hydroxydecanoic acidIBA
06/2005 - 10/2002
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 04/2003
4Digoxin (Digitek)FDA LinkGeneric
02/2012 - 10/2003
4Adenosine Triphosphate (ATP)IBA
01/2006 - 06/2002
3Nitric Oxide Synthase (NO Synthase)IBA
10/2015 - 01/2005
3NG-Nitroarginine Methyl Ester (L-NAME)IBA
01/2014 - 07/2002
3Dopamine (Intropin)FDA LinkGeneric
02/2012 - 10/2003
3manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA
06/2007 - 02/2003
3simendan (Levosimendan)IBA
03/2006 - 10/2003
2IsofluraneFDA LinkGeneric
10/2015 - 12/2014
2Vasopressins (Vasopressin)IBA
01/2013 - 11/2011
2Superoxides (Superoxide)IBA
03/2012 - 04/2003
2DobutamineFDA LinkGeneric
01/2006 - 10/2003
2Flavin-Adenine Dinucleotide (FAD)IBA
09/2005 - 06/2005
2mitochondrial K(ATP) channelIBA
06/2005 - 10/2002
2Anesthetics (Anesthetic Agents)IBA
05/2004 - 04/2003
1mitochondrial permeability transition poreIBA
10/2015
1Epinephrine (Adrenaline)FDA LinkGeneric
02/2015
1Poloxamer (Poloxamer 407)IBA
02/2015
1Apolipoproteins C (ApoC)IBA
12/2014
1Butorphanol (BC 2627)FDA LinkGeneric
01/2014
1remifentanil (Ultiva)FDA Link
01/2014
1deoxymyoglobinIBA
01/2014
1Fentanyl (Sublimaze)FDA LinkGeneric
01/2014
1Methadone (Dolophine)FDA LinkGeneric
01/2014
1Morphine (MS Contin)FDA LinkGeneric
01/2014
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2014
1Opioid Analgesics (Opioids)IBA
01/2014
1Opioid Peptides (Opioid Peptide)IBA
01/2014
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2013
1Angiotensin Receptor AntagonistsIBA
01/2013
1AngiotensinsIBA
01/2013
1Dihydrotachysterol (AT 10)IBA
02/2012
1Superoxide DismutaseIBA
01/2005
1Glutathione (Reduced Glutathione)IBA
01/2005
1CatalaseIBA
01/2005
1Nifedipine (Adalat)FDA LinkGeneric
08/2004
1diacetylmonoxime (KBDO)IBA
08/2004
1bimakalimIBA
08/2004
1Lidocaine (Xylocaine)FDA LinkGeneric
08/2004
1Hypoglycemic Agents (Hypoglycemics)IBA
05/2004
1Cyclooxygenase InhibitorsIBA
05/2004
1Cardiotonic Agents (Cardiac Stimulants)IBA
10/2003
1ManganeseIBA
04/2003
1PotassiumIBA
04/2003
1dimemorfan (AT 17)IBA
10/2002

Therapy/Procedure

3Resuscitation
02/2015 - 11/2011
2Cardiopulmonary Resuscitation (CPR)
02/2015 - 12/2014
1Ischemic Postconditioning
02/2015
1General Anesthesia
01/2013
1Induced Heart Arrest (Cardioplegia)
03/2012
1Advanced Cardiac Life Support (Life Support, Advanced Cardiac)
11/2011
1Anesthesia
05/2004
1Rewarming
02/2004